Neuroprotectin D1 is synthesized in the cone photoreceptor cell line 661W and elicits protection against light-induced stress.

Docosahexaenoic acid (DHA), an omega-3 fatty acid family member, is obtained by diet or synthesized from dietary essential omega-3 linolenic acid and delivered systemically to the choriocapillaris, from where it is taken up by the retinal pigment epithelium (RPE). DHA is then transported to the inner segments of photoreceptors, where it is incorporated in phospholipids during the biogenesis of outer segment disk and plasma membranes. As apical photoreceptor disks are gradually shed and phagocytized by the RPE, DHA is retrieved and recycled back to photoreceptor inner segments for reassembly into new disks. Under uncompensated oxidative stress, the docosanoid neuroprotectin D1 (NPD1), a potent mediator derived from DHA, is formed by the RPE and displays its bioactivity in an autocrine and paracrine fashion. The purpose of this study was to determine whether photoreceptors have the ability to synthesize NPD1, and whether or not this lipid mediator exerts bioactivity on these cells. For this purpose, 661W cells (mouse-derived photoreceptor cells) were used. First we asked whether these cells have the ability to form NPD1 by incubating cells with deuterium (d4)-labeled DHA exposed to dark and bright light treatments, followed by LC-MS/MS-based lipidomic analysis to identify and quantify d4-NPD1. The second question pertains to the potential bioactivity of these lipids. Therefore, cells were incubated with 9-cis-retinal in the presence of bright light that triggers cell damage and death. Following 9-cis-retinal loading, DHA, NPD1, or vehicle were added to the media and the 661W cells maintained either in darkness or under bright light. DHA and NPD1 were then quantified in cells and media. Regardless of lighting conditions, 661W cells acquired DHA from the media and synthesized 4-9 times as much d4-NPD1 under bright light treatment in the absence and presence of 9-cis-retinal compared to cells in darkness. Viability assays of 9-cis-retinal-treated cells demonstrated that 34 % of the cells survived without DHA or NPD1. However, after bright light exposure, DHA protected 23 % above control levels and NPD1 increased protection by 32 %. In conclusion, the photoreceptor cell line 661W has the capability to synthesize NPD1 from DHA when under stress, and, in turn, can be protected from stress-induced apoptosis by DHA or NPD1, indicating that photoreceptors effectively contribute to endogenous protective signaling mediated by NPD1 under stressful conditions.

Effects of levamisole on normal and malignant murine lymphocytes.

Levamisole enhanced transformation of murine lymphocytes stimulated either by mitogens or allogeneic lymphocytes. In a similar dose-dependent pattern it stimulated in vitro growth of L1210, P1798, and 6C3HED but not YAC lymphoma cells. Stimulation of growth of lymphoma cells was greater by peritoneal cells harvested from normal mice 4 days after levamisole injection than by peritoneal cells from untreated mice. This effect correlated with the shortened survival time of BALB/c mice treated with levamisole prior to P1798 implantation compared to that of a control group not pretreated. Administration of levamisole with iodoacetamide-modified tumor cells in immunoprophylaxis studies had no effect on the rejection of a tumor implant or on development of tumor-specific antibody. Levamisole was added to regimens involving asparaginase therapy of 6C3HED-bearing C3H mice and chemoimmunotherapy of BALB/c mice bearing P1798 with methotrexate and iodoacetamide-modified P1798 cells. In neither case were there increased numbers of survivors, and mean survival time was generally decreased for the levamisole-treated groups. The stimulated tumor growth may have been mediated by a direct effect of levamisole on the lymphoma cells, through an effect on other cell types, or by both effects; these effects apparently outweighed potentially beneficial effects of levamisole on the immune system.

Enhanced response to chemoimmunotherapy and immunoprophylaxis with the use of tumor-associated antigens with a lipophilic agent.

Treating iodoacetamide (IAD)-modified lymphoma cells with the lipophilic agent dimethyldioctadecylammonium bromide (DDA) increased their immunogenicity as evidenced by the increased capacity of syngeneic, vaccinated hosts to reject subsequent implants of the same lymphoma. Under conditions of suboptimal immunization to facilitate comparison, there were 61% survivors among mice challenged with tumor implants after immunization with modified cells and DDA compared to 20% survivors among those immunized in the absence of DDA. The enhanced immune response was dependent on DDA dosage and was most striking when DDA was directly complexed to the IAD-treated cells. DDA was also effective with solubilized tumor antigen and with lymphoma cells not pretreated with IAD, but the latter had to be heat killed to assure that they were nontumorigenic. In therapy experiments BALB/c mice bearing P1798 were treated with methotrexate followed by immunotherapy with IAD-P1798 alone or complexed to DDA. With two and three cycles of therapy, methotrexate alone yielded 5 and 13% survivors, while adding immunotherapy with the DDA complex gave survival rates of 63 and 71%. In the absence of DDA, chemoimmunotherapy with methotrexate and IAD-P1798 gave intermediate results. In the absence of antigen, DDA was ineffective in either immunoprophylaxis or therapy experiments.

Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.

DNA synthesis by murine lymphoma cells was stimulated up to 20-fold in vitro by syngeneic or allogeneic peritoneal cells (PEC) and peripheral blood lymphocytes, as measured by [3H]thymidine incorporation in a 44-hr assay. The increase in DNA synthesis correlated with an increase in tumor cell number in the cultures. The adherent PEC population was responsible for most of the enhancement. This effect was abrogated by pretreating the adherent cells with the metabolic inhibitors iodoacetamide, KCN, NaF, and dinitrophenol, or with glutaraldehyde, or by heating at 56 degrees. Pretreatment with mitomycin C did not eliminate the stimulatory effect. PEC supernatants did not enhance tumor growth, but effector-to-target cell proximity was shown to be necessary for stimulation. PEC from tumor-immunized mice also stimulated tumor target cell growth, but to a consistently smaller degree than did nonimmune PEC. This immune inhibition correlated with in vivo survival of mice to live tumor challenge and with ability of effector cells to increase life-span in adoptive immunity tests. Differential production of thymidine by normal and immune PEC appeared not to be a factor in these assays. Fractionation of PEC showed that the immune nonadherent cells were inhibitory in vitro and were able to increase survival time in adoptive immunity tests. On the other hand, the adherent PEC from immune mice either inhibited, stimulated, or had no effect on tumor cell DNA synthesis, compared with nonimmune adherent PEC, thus exhibiting no correlation with the immune status of the donor. In one example, administration of the macrophage activator lipopolysaccharide to mice resulted in PEC that were inhibitory in the in vitro assay, although the agent did not produce in vivo immunity. The inhibition of tumor DNA synthesis assay, with unfractionated PEC, exhibited a consistent correlation with the immune status of the host when mice were sensitized to lymphoma cells. However, the variable influence of the adherent PEC population on tumor growth reduced or nullified the immune inhibitory effect in a few cases.

Tubocurarine chloride inhibits rod outer segment shedding in the frog retina.

The cholinergic postsynaptic neuromuscular blocker, tubocurarine chloride (curare), attenuates the rod shedding response of the frog in a dose-dependent manner. Injections of curare into the dorsal lymph sacs or intraocularly into the vitreous of the eye produced similar results. Intraocular injections of Ringer solution of varying quantities of 0.9% NaCl (the carrier solution of the commercially prepared curare), had no adverse effect on the shedding response. Additionally, injections of curare into one eye had no effect on the rod shedding rate of the other eye.

Visualization of [3H]docosahexaenoic acid trafficking through photoreceptors and retinal pigment epithelium by electron microscopic autoradiography.

PURPOSE: [3H]docosahexaenoic (DHA) acid was followed through the retinal pigment epithelial cells and photoreceptors for up to 5 days after injection to specifically determine which membrane systems of the retinal pigment epithelial cells are used in the handling of [3H]DHA after shedding and phagocytosis of rod tips. METHODS: Frogs (Rana pipiens) were injected with [3H]DHA in the dorsal lymph sacs, and maintained for up to 5 days. Retinas were processed for electron microscopic autoradiography, stored for various periods of time, and then analyzed by transmission electron microscopy. RESULTS: After 1 day, [3H]DHA had accumulated within photoreceptor ellipsoids, and had begun to appear as dense label in newly formed discs. By day 5, the basal region of dense label had expanded apically. Newly shed rod outer segment tips were diffusely labeled; but occasionally after several hours, they acquired additional label as they moved near Bruch's membrane. Retinal pigment epithelial cytoplasm maintained a constant level of label, with myeloid bodies sometimes slightly labeled. Oil droplets of the retinal pigment epithelium accumulated dense label throughout this study. CONCLUSIONS: When [3H]DHA enters the retinal pigment epithelium, some is retained within oil droplets, whereas the rest is passed on to the photoreceptors. [3H]DHA is initially taken up by inner segments and then dispersed to photoreceptor synaptic terminals as well as to ellipsoids where discs are assembled. Phagosomal labeling exactly matches rod outer segment tips, but occasionally increases as degradation occurs near Bruch's membrane. Normally, density of label remains constant throughout the degradation process.

Localization of lipocalin-type prostaglandin D synthase (beta-trace) in iris, ciliary body, and eye fluids.

PURPOSE: Prostaglandin (PG) D synthase is present in neural tissues and cerebrospinal fluid (beta-trace). This enzyme belongs to the lipocalin family which consists of transporter proteins for lipophilic substances in the extracellular space. PGD synthase is found in retinal pigment epithelium, from where it is secreted into the interphotoreceptor matrix. The authors have undertaken the localization of this unique enzyme within the tissues and spaces of the anterior segment of the eye. METHODS: Iris, ciliary body, lens, and aqueous and vitreous humors were collected from adult rats and mice. PGD synthase activity was determined, and the protein was quantified by Western blot analysis and localized immunohistochemically. Finally, in situ hybridization was performed to localize PGD synthase mRNA. RESULTS: PGD synthase was most abundant in the aqueous and vitreous humors. It was less abundant in tissue cytosolic fractions; these fractions had almost 10-fold as much as their corresponding membrane-bound fractions. Lens tissue had the lowest amount observed. PGD synthase was localized to the epithelial cells of the iris and the ciliary body and to the adjacent extracellular chambers, but PGD synthase mRNA was found only within the epithelial cells. Several glycosylated forms of PGD synthase were also detected. CONCLUSIONS: PGD synthase was synthesized within the epithelial cells of the iris and the ciliary body and was then secreted into the aqueous and vitreous humors, where it accumulated as an active enzyme.

Immunogenicity of modified tumor cells in syngenic hosts.

Modified tumor cells were used to immunize three murine hosts against syngenic ascitic lymphomas: C3H-6C3HED, BALB/c-P1798, and DBA/2-L1210. When the host was capable of a significant immune response against the malignant cells during progressive tumor growth (e.g., C3H vs. 6C3HED), protective immunization against a larger challenge tumor dose was achieved after fewer vaccinations. Lipopolysaccharide (LPS) enhanced host response to iodoacetamide (IAd) modified P1798 and L1210 so as to confer resistance after fewer immunizations with these weakly antigenic tumors. Similarities among the three systems were also seen. Modified cells may be stored at 4 degrees C several weeks and are effective when 107-108 are given i.p.; resistance appears maximal about one week after vaccination. In immunotherapy trials, C3H mice implanted with 5 x 104 6C3HED cells and treated at least four times with IAd-6C3HED demonstrated a 25% cure rate. A model was presented for evaluating parameters of response to immunotherapy in conjunction with chemotherapy. Cell-mediated immunity in resistant mice was demonstrated by inhibition of DNA synthesis in cultures of lymphoma cells and sensitized peritoneal cells (PEC) compared to that with nonimmune PEC. This assay system may also provide an opportunity for examining the hypothesis of immunostimulation of tumor growth in vitro. Humoral response to modified cells was established by membrane immunofluorescence. Although anti-6C3HED and anti-L1210 appear specific, anti-P1798 antiserum reacts with BALB/c thymocytes and murine fetal antigen.

Presenilin-2 (PS2) expression up-regulation in a model of retinopathy of prematurity and pathoangiogenesis.

Presenilin-2 (PS2; AD4), a regulator of intercellular signaling during CNS development and cell fate determination, appears to be involved in pathogenic processing of beta-amyloid precursor protein (betaAPP) into potentially neurotoxic beta-amyloid (Abeta) peptides. The PS2 gene promoter contains multiple DNA binding sites for the relatively rare hypoxia-inducible transcription factor HIF-1, suggesting that PS2 expression may be a sensitive indicator of decreased oxygen availability. We have used a cycled hypoxia/hyperoxia (10-50% O2) protocol followed by normoxia (20% O2) as a retinal model of retinopathy of prematurity to induce neovascularization (NV) in rat pups. Retinal cell nuclear extracts from pups undergoing hypoxia exhibited a dramatic increase in HIF-1-DNA binding, followed by a delayed (2-7 day) elevation of PS2 RNA message and protein. PS2 gene activation during hypoxia may direct cellular fate towards pathoangiogenesis and intercellular PS2-mediated signaling dysfunction.

Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy.

We performed an immunohistologic study on 11 specimens of epiretinal membranes surgically obtained from patients who had rhegmatogenous retinal detachment with proliferative vitreoretinopathy. Immunostaining procedures were used to identify immunoglobulin and complement deposits, to visualize class II antigen expression by proliferating cells, and to determine eventual infiltration by cells of the immune system. Diffuse deposits of IgG, IgA, IgE, C1q, C3c, and C3d were found in epiretinal membranes, whereas numerous cells, including glial or pigmented epithelial cells, expressed HLA-DR and HLA-DQ antigens. Some macrophages and B or T8 lymphocytes were identified. These results suggest activation of the immune system during the course of proliferative vitreoretinopathy. Class II antigen expression could be dependent upon growth-promoting factors and interferon gamma and could play a crucial role in this immune reaction, which resulted in immunoglobulin deposition and activation of complement. However, the eventual role of immune phenomena in the extension of proliferative processes remains to be determined.

Class II antigen expression in diabetic preretinal membranes.

Using immunofluorescence and immunoperoxidase procedures, we found large amounts of IgG, IgA, IgM, and IgE, as well as C1q, C3c, and C3d, in the connective stroma and within the vascular walls on eight specimens of preretinal membranes obtained from diabetic patients with proliferative retinopathy. The membranes contained many isolated human leukocyte antigen (HLA) DR- and DQ-expressing cells, and vascular endothelial cells strongly expressed class II determinants. Monoclonal antibodies to immunocompetent cells disclosed only rare B lymphocytes or suppressor/cytotoxic T cells and few monocytes. These findings confirm previous evidence of immune reactions in the pars plana of patients with proliferative diabetic retinopathy, and suggest that an autoimmune reaction is a factor in this complication. It is yet not possible to determine whether this reaction is a nonspecific consequence of the vasoproliferative processes or if it plays a direct role in the development and extension of preretinal membranes.

Local stimulation induces shedding throughout the frog retina.

Our previous work has demonstrated that rod shedding in the frog retina can be driven by environmental cues such as light onset. Although shedding normally occurs binocularly, we found that shedding could be initiated independently in either eye of the frog by monocular stimulation. Further, rod shedding occurs in vitro in the isolated eyecup under appropriate incubation conditions when provided with a light stimulus following a dark incubation period. Thus, the control mechanism for light induced rod shedding in the frog seems to be located within the eye, and does not seem to be systemically or centrally located. However, the exact link between light onset and shedding of the distal rod tips remains unknown. To elucidate further the control site for initiation of rod shedding, we used a variety of stimulus conditions, including front and rear screens as well as spots and slits projected directly on the retina, to stimulate a small portion of the frog retina with a range of light intensities and stimulus paradigms. In all cases where shedding occurred, it was uniform throughout the retina. Thus, it appears that the light-cued message received by a small population of photoreceptors is sufficient to initiate shedding throughout the retina. These results differ significantly from those found by Easter and Macy for light-induced photomechanical movements, which were found to be locally controlled.

Selective facilitation of memory attributes by strychnine.

In two experiments, the effects of strychnine on the specific memory attributes of prior discrimination training were assessed in terms of subjects' performance under various discrimination reversal conditions. Mice were trained in a discrimination task with two redundant relevant cues. Immediately after their last training trial, subjects were administered an intraperitoneal injection of either strychnine (1.0 mg/kg) or saline. When both training cues were reversed (Experiment 1), strychnine treated subjects were observed to exhibit greater performance decrements than saline-treated subjects upon initial exposure to reversal conditions, suggesting that strychnine had enhanced the memory of a relatively specific stimulus-response association. When subjects were tested under partial cue-reveraal conditions (Experiment 2) strychnine treated animals exhibited treater utilization of one of the redundant relevant stimuli than the other, while saline-treated animals exhibited no preference.

Facilitation of the long term memory store with strychnine: a reexamination.

Contrary to previous findings, some recent studies have reported that several daily injections of strychnine, beginning 24 hr after learning, facilitates subsequent retention. The present paper reports 3 studies using mice which suggest that strychnine has no effect on retention when the learning-injection interval is 24 hr. This absence of an effect was found using a range of strychnine doses. Furthermore, the absence of the facilitation effect was found not to be due to any failure of animals to learn prior to injection or to the fact that all animals performed asymptotically on the retention test.

Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis.

The involvement of retinal pigment epithelial (RPE) cells in the recycling of docosahexaenoic acid (DHA), from phagocytized disc membranes back to the retina, was studied in frogs subsequent to injection of [3H]DHA via the dorsal lymph sac. Rod outer segments (ROS) gradually accumulated [3H]DHA as a dense, heavily labeled region that arrived at the distal tips by 28 days post-injection. Autoradiographic analysis at the time of maximal shedding and phagocytosis (1-2 hr after the onset of light) showed diffusely (before 28 days) and heavily (after 28 days) labeled phagosomes in RPE cells. Biochemical analysis of the [3H]DHA-containing lipids of discs that contribute to the labeling of RPE cells after phagocytosis was also performed. Between 27 and 34 days, when 12% of retinal [3H]DHA-lipids present in disc membranes are phagocytized by RPE cells, total retinal labeling remained unchanged. Taken together, these data suggest that the [3H]DHA of the densely labeled region of the ROS was recycled back to the photoreceptor cells only after it had reached the RPE cells following 28 days post-injection. We conclude that, following daily phagocytosis of ROS tips, RPE cells play a central role in the conservation and redelivery of ROS-derived DHA back to photoreceptor cells through the interphotoreceptor matrix.

Docosahexaenoic acid is taken up by the inner segment of frog photoreceptors leading to an active synthesis of docosahexaenoyl-inositol lipids: similarities in metabolism in vivo and in vitro.

Retinal uptake and metabolism of docosahexaenoic acid (DHA) was studied in vivo in frogs 1, 2, and 6 hours after dorsal lymph sac injections of [3H]-DHA (50 microCi/g). Light microscope autoradiography and biochemical techniques were used to compare the profiles of cellular uptake and lipid labeling with those obtained from 6 hour [3H]-DHA retinal incubations (final DHA concentration, 0.11 and 25 microM). Light microscope autoradiography demonstrated that rod photoreceptor ellipsoids and synaptic terminals preferentially labeled both in vivo and in vitro conditions. Also, the cytoplasm and oil droplets of retinal pigment epithelial cells became very heavily labeled after 6 hours of in vivo labeling. Phosphatidic acid showed the highest labeling in one hour, while other phospholipids accumulated label throughout the 6 hours. At that time point, most label was recovered in phosphatidyl-ethanolamine (37%), phosphatidylcholine (27%), and phosphatidylinositol (16%), the latter displaying 1.6-fold higher labeling than phosphatidylserine. The profile of labeled lipids was similar to that obtained in vitro when the concentration of DHA was in the nanomolar range. Our results suggest that de novo lipid synthesis is a major route for esterification of [3H]-DHA into retinal lipids, giving rise to an early and rapid labeling of DHA-phosphatidylinositol, both in vivo and in vitro, when DHA is present at low concentrations. Furthermore, the profile of labeled retinal cells under in vivo conditions closely resembles in vitro DHA labeling.

Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process.

After 18:3 omega 3 is obtained from the diet, it is accumulated by the liver, where it is esterified and temporarily stored as triacylglycerols. As it is required, 18:3 omega 3 is elongated and desaturated to 22:6 omega 3, then released into the circulation with lipoprotein carriers. RPE cells remove the 22:6 omega 3 from the choriocapillaris and subsequently release it to the retina proper. In the frog, all 22:6 omega 3 input to the photoreceptors occurs by way of the RPE cells. After passing through the interphotoreceptor matrix, it is selectively taken into the myoid region of photoreceptor cells where it is immediately activated and esterified onto position 2 (and sometimes also position 1) of a glycerol molecule. Some phospholipids are passed through the endoplasmic reticulum and Golgi apparatus, while others are not. Generally, transport to the outer segments seems to be independent of the Golgi apparatus. Addition to rod outer segments occurs in two ways: i) a general diffuse pathway, probably common to all fatty acids, which rapidly labels the entire outer segment; and ii) a specific dense pathway, utilized only by 22:6 omega 3-containing phospholipids, which become locked into the matrix of disc membranes along with opsin. There appears to be no exchange between these two forms of label. Accumulation of newly synthesized basal discs pushes older, 22:6 omega 3-laden discs apically until the outer segment tips, high in 22:6 omega 3-phospholipids (the dense form of outer segment label), are shed into the RPE cytoplasm. There, as the 22:6 omega 3 fatty acids are released from the disc membranes during degradation, a recycling mechanism immediately directs these essential fatty acids back into the interphotoreceptor matrix, thus conserving this molecule in the retina, and permitting it to be again selectively taken up by the photoreceptors for photomembrane synthesis. The process of 22:6 omega 3 handling and trafficking by the retina is specifically orchestrated around a conservation mechanism that is regulated by the RPE cells and that ensures, through a short feedback loop from the phagosomes to the interphotoreceptor matrix, adequate levels of 22:6 omega 3 for photoreceptors at all times.

A new look at peripheral vascular disease in blacks: a two-year update.

A comprehensive overview of 66 patients-the majority of whom were black-undergoing distal lower extremity revascularization for severe atherosclerotic ischemia with impending limb loss is presented. Twenty-five patients are presently two-years postoperative, 19 are one-year post revascularization, and 22 are new additions having undergone revascularization within the last year.Patients in the study group are presented according to race, sex, and age. Their histories and pre-operative clinical conditions, along with angiographic and operative findings lead to the identification of a previously undescribed atherosclerotic phenomenon present among blacks. The impact of an aggressive program for limb salvage is reported and the prospect of avoiding needless limb loss is discussed.

Immunohistological study of subretinal membranes in age-related macular degeneration.

An immunohistological study was performed on 6 specimens of subretinal membranes obtained surgically from patients suffering from age-related disciform macular degeneration. using immunoperoxidase procedures, we found in those membranes large amounts of IgG, IgA and IgE as well as C1q, C3c and C3d complement components diffusely distributed in the connective stroma and within the new blood vessel walls. Moreover, subretinal membranes contained numerous isolated HLA-DR- and -DQ-expressing cells, including glial, pigment epithelial and vascular endothelial cells. Monoclonal antibodies to immunocompetent cells disclosed only rare B and natural killer lymphocytes or suppressor-cytotoxic T cells, as well as some monocytes. These results show that immune phenomena are involved in proliferative changes associated with subretinal neovascularization. In addition, they suggest there are interactions between the immune system and peptide growth factors.

Experimental models and their use in studies of diabetic retinal microangiopathy.

Diabetes produces dramatic changes in retinal microvasculature, triggering endothelial cell proliferation and microaneurysms. Capillaries become weakened, releasing blood into vitreal and retinal spaces. Photoreceptors become occluded and separated from the choriocapillaris, resulting in visual acuity decline, detachment and cell death. Several models have been developed that have proved useful for the study of this disease, resulting in a better understanding of the processes involved. Streptozotocin treatment affects the pancreatic beta cells, rapidly reducing them until insulin is no longer synthesized in sufficient amounts. The galactosemic model shifts metabolism away from glucose, increasing aldose reductase and retinal polyol metabolism. Finally, two weeks of cycled oxygen from high to low tension every 24 hours, followed by return to room air, triggers microangiogenesis in developing retinas. Use of these models, separately or in combination, as well as electroretinographic analysis, has begun to reveal the events taking place as diabetic retinopathy progresses. Endothelial cells become separated from pericytes as basement membranes thicken, and vascular endothelial growth factor increases, triggering their proliferation. Finally, early changes occurring within photoreceptors can now be studied.